For decades, “private credit” was synonymous with rigid structures and standardized term loans with fixed covenants that resembled off-the-shelf products. That’s changing. Today, what’s broadly known as private debt – which includes middle-market leveraged buyout (LBO) lending, asset-based lending, and venture debt – is emerging as a flexible capital solution, designed to reflect how individual companies actually operate, scale, and weather uncertainty.
Much of the growth in private credit has come from middle-market lending that shifted from banks to non-bank institutions in the years since the financial crisis. But within that broader transformation, venture debt has quietly become one of the most important tools for founders by providing capital that complements equity rather than takes it.
The timing of this shift comes down to several key factors. Equity markets remain tight while venture capital sentiment is cautious, and fundraising cycles have stretched. IPOs are scarce, M&A exits are muted, and many venture funds are struggling to raise fresh capital amid these conditions. Founders are understandably reluctant to raise equity at down-round valuations that heavily dilute ownership, yet unpredictable cash flows and market volatility make growth capital as necessary as ever. Into this gap has stepped a new generation of venture debt and private credit providers, offering bespoke structures aligned with business realities.
Consider OrbiMed’s recent $1.86 billion royalty and credit fund, which highlights the scale of investor appetite for customized debt in life sciences. Or take a $20 million facility designed for Swing Education that blended a first-lien loan with a revolving line of credit structured specifically around the company’s cash cycle. These examples underscore the broader trend: the “one-size-fits-all” model of credit is being replaced by revenue-based financing, hybrid debt-equity instruments, revolving facilities, and milestone-based drawdowns. For founders, this means capital that flexes with the business rather than forcing the company to contort to rigid terms.
Venture debt is especially valuable in new-age industries with varied revenue profiles. Take a biotech company, for example, which could choose to finance late-stage clinical trials with structured loans. Alternatively, a SaaS platform could secure a unitranche facility to support global expansion. Even non-venture-backed businesses, such as family-owned enterprises or subsidiaries of larger corporations, are increasingly turning to private debt to fuel growth without sacrificing ownership.
The real flexibility of venture debt lies in alignment. A lender with rigid tendencies and terms can quickly become a liability at the first sign of concern; however, an adaptable financing structure, paired with a patient and seasoned lending partner, helps companies navigate volatility and emerge stronger. Diverse options and tailored outcomes may explain why many late-stage companies are exploring venture debt alongside, or even in place of, dilutive equity. Flexibility in structure gives founders a chance to maintain control without diluting ownership, and make financing work in support of their vision, rather than adjusting their strategy to fit the constraints of capital.
Last year, the global private debt market eclipsed $1.5 trillion and is on track to nearly double to $2.8 trillion by 2028. That growth reflects rising demand for capital solutions that expand optionality rather than constrain it. Its popularity stems from the non-dilutive nature of these structures since organizations can extend runway between equity rounds, finance acquisitions, or pursue geographic expansion without needing to tap equity investors. Most facilities are designed to flex with conditions, which gives companies breathing room when markets turn volatile and allows founders to make prudent, thoughtful decisions instead of reacting to every short-term signal.
In 2021 and 2022, equity markets poured capital into companies and valuations soared, sometimes to unsustainable levels. When conditions shifted in 2023 and 2024, fundraising cycles grew longer and capital availability tightened. For many founders, that meant a more challenging environment to raise equity on favorable terms. At the same time, it also highlighted the role of flexible financing as a stable option for growth that can complement (rather than replace) traditional venture channels.
The evolution of venture debt into flexible capital represents more than a shift in product design; it reflects a pattern that great companies are not built on basic financing, but rather on trust, bespoke solutions, and capital that works with (not against) the founder’s vision. This shift in structure has implications for entrepreneurs and their backers. For founders, the challenge is no longer whether to consider private credit, but instead to determine which blend of credit and equity positions the business for sustainable, long-term growth. The right structure can protect equity, preserve influence, and provide more strategic options. For investors, the shift positions private debt as a complement, supplement, or alternative to equity, not a competition, offering differentiated returns and capital resiliency in an uncertain environment.
As we settle into 2026, the rise in venture and growth debt deals will likely continue to grow. Founders who treat capital like a dynamic, strategic tool rather than a simple resource or line item will be best positioned to thrive. Ultimately, the next batch of successful companies will be the firms that secure financing aligned with their growth trajectory, choosing partners willing to meet them with flexibility, not fussiness.
